BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 22880716)

  • 1. Soft tissue extension increases the risk of local recurrence after curettage with adjuvants for giant-cell tumor of the long bones.
    van der Heijden L; van de Sande MA; Dijkstra PD
    Acta Orthop; 2012 Aug; 83(4):401-5. PubMed ID: 22880716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgery methods and soft tissue extension are the potential risk factors of local recurrence in giant cell tumor of bone.
    Li D; Zhang J; Li Y; Xia J; Yang Y; Ren M; Liao Y; Yu S; Li X; Shen Y; Zhang Y; Yang Z
    World J Surg Oncol; 2016 Apr; 14():114. PubMed ID: 27094617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy.
    ; Becker WT; Dohle J; Bernd L; Braun A; Cserhati M; Enderle A; Hovy L; Matejovsky Z; Szendroi M; Trieb K; Tunn PU
    J Bone Joint Surg Am; 2008 May; 90(5):1060-7. PubMed ID: 18451399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended intralesional curettage preferred over resection-arthrodesis for giant cell tumour of the distal radius.
    Abuhejleh H; Wunder JS; Ferguson PC; Isler MH; Mottard S; Werier JA; Griffin AM; Turcotte RE
    Eur J Orthop Surg Traumatol; 2020 Jan; 30(1):11-17. PubMed ID: 31297594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mid-term results of intralesional extended curettage, cauterization, and polymethylmethacrylate cementation in the treatment of giant cell tumor of bone: A retrospective case series.
    Şirin E; Akgülle AH; Topkar OM; Sofulu Ö; Baykan SE; Erol B
    Acta Orthop Traumatol Turc; 2020 Sep; 54(5):524-529. PubMed ID: 33155564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of giant cell tumor of distal radius with limited soft tissue invasion: Curettage and cementing versus wide excision.
    Mozaffarian K; Modjallal M; Vosoughi AR
    J Orthop Sci; 2018 Jan; 23(1):174-179. PubMed ID: 29110910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid nitrogen or phenolization for giant cell tumor of bone?: a comparative cohort study of various standard treatments at two tertiary referral centers.
    van der Heijden L; van der Geest IC; Schreuder HW; van de Sande MA; Dijkstra PD
    J Bone Joint Surg Am; 2014 Mar; 96(5):e35. PubMed ID: 24599207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supplemental Bone Grafting in Giant Cell Tumor of the Extremity Reduces Nononcologic Complications.
    Benevenia J; Rivero SM; Moore J; Ippolito JA; Siegerman DA; Beebe KS; Patterson FR
    Clin Orthop Relat Res; 2017 Mar; 475(3):776-783. PubMed ID: 26932739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-depth analysis of local recurrence of giant cell tumour of bone with soft tissue extension after intralesional curettage.
    Chen L; Ding XY; Wang CS; Si MJ; Du LJ; Zhang WB; Lu Y
    Radiol Med; 2014 Nov; 119(11):861-70. PubMed ID: 24604549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Strategy of Curettage and Adjuvant Microwave Therapy for the Treatment of Giant Cell Tumor of Bone in Extremities: A Preliminary Study.
    Ke J; Cheng S; Yao MY; Chu X; Wang M; Zeng XL; Yang T; Zhang C; Zhong H; Zhang Y
    Orthop Surg; 2021 Feb; 13(1):185-195. PubMed ID: 33442922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative Denosumab With Curettage and Cryotherapy in Giant Cell Tumor of Bone: Is There an Increased Risk of Local Recurrence?
    Scoccianti G; Totti F; Scorianz M; Baldi G; Roselli G; Beltrami G; Franchi A; Capanna R; Campanacci DA
    Clin Orthop Relat Res; 2018 Sep; 476(9):1783-1790. PubMed ID: 30778015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Giant cell tumor with pathologic fracture: should we curette or resect?
    van der Heijden L; Dijkstra PD; Campanacci DA; Gibbons CL; van de Sande MA
    Clin Orthop Relat Res; 2013 Mar; 471(3):820-9. PubMed ID: 22926445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment options for recurrent giant cell tumors of bone.
    Balke M; Ahrens H; Streitbuerger A; Koehler G; Winkelmann W; Gosheger G; Hardes J
    J Cancer Res Clin Oncol; 2009 Jan; 135(1):149-58. PubMed ID: 18521629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curettage as first surgery for bone giant cell tumor : adequate surgery is more important than oncology training or surgical management by high volume specialized teams.
    Tsukamoto S; Mavrogenis AF; Tanzi P; Leone G; Akahane M; Tanaka Y; Errani C
    Eur J Orthop Surg Traumatol; 2020 Jan; 30(1):3-9. PubMed ID: 31520122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Giant cell tumour of bone.
    Aoude A; Nikomarov D; Perera JR; Ibe IK; Griffin AM; Tsoi KM; Ferguson PC; Wunder JS
    Bone Joint J; 2023 May; 105-B(5):559-567. PubMed ID: 37121582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the use of polymethyl-methacrylate cement after intralesional curettage of giant cell tumors of appendicular bone guarantee reduced local recurrence rates? A retrospective analysis.
    Colding-Rasmussen T; Horstmann PF; Jørgensen PH; Hettwer W; Hansen BH; Tierp-Wong CNE; Petersen MM
    J Orthop Surg (Hong Kong); 2023; 31(3):10225536231202155. PubMed ID: 37688488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent giant cell tumor of long bones: analysis of surgical management.
    Klenke FM; Wenger DE; Inwards CY; Rose PS; Sim FH
    Clin Orthop Relat Res; 2011 Apr; 469(4):1181-7. PubMed ID: 20857250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-grade chondrosarcoma of long bones treated with intralesional curettage followed by application of phenol, ethanol, and bone-grafting.
    Verdegaal SH; Brouwers HF; van Zwet EW; Hogendoorn PC; Taminiau AH
    J Bone Joint Surg Am; 2012 Jul; 94(13):1201-7. PubMed ID: 22760388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors of fracture following curettage for bone giant cell tumors of the extremities.
    Tsukamoto S; Mavrogenis AF; Akahane M; Honoki K; Kido A; Tanaka Y; Donati DM; Errani C
    BMC Musculoskelet Disord; 2022 May; 23(1):477. PubMed ID: 35590280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors for local recurrence in extremity-located giant cell tumours of bone with pathological fracture.
    Medellin MR; Fujiwara T; Tillman RM; Jeys LM; Gregory J; Stevenson JD; Parry M; Abudu A
    Bone Joint J; 2018 Dec; 100-B(12):1626-1632. PubMed ID: 30499317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.